ClinicalTrials.gg
RecruitingNCT05619705Updated Jun 8, 2026

Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women

An interventional study of Healthy for Two-Health Coaching (H42) and Maintain Healthy in Pregnancy and Postpartum(mHIPP) in Postpartum Weight Retention, Pregnancy Weight Gain and Overweight and Obesity, sponsored by Johns Hopkins University. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-08.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Apr 2023; still recruiting 3 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
360
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 61 studies in Gestational Weight Gain with a site in United States — 12 open to participants now, 15 under way, none of them phase 3. Gestational Weight Gain · United States.

Planned enrollment
11th of 55
360 · median 70
Started
2023
with 9 others
No phase
53 of 61
11 open now
Primary completion
2026-12
later than 4 of 14 live
Registered
46th of 61
by date
Lead sponsor
2 of 61
Johns Hopkins University

Among the 61 studies in Gestational Weight Gain with a site in United States, this one is the 11th largest by planned enrollment of the 55 interventional ones that give a count, is one of 10 that started in 2023, is one of 53 with no phase, reaches primary completion later than 4 of the 14 other live ones, and was the 46th registered.

Gestational Weight Gain

135 studies on the registry are indexed under Gestational Weight Gain; 24 are open to participants now.

Browse Gestational Weight Gain studies →

Open to participants now

12 of the 61 studies in Gestational Weight Gain with a site in United States are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 21 Gestational Weight Gain studies recruiting now, 7 (33%) set no upper age limit and 14 (67%) stop at 75 or younger; 4 take children under 18; 12 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 61 studies in Gestational Weight Gain with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to compare the effectiveness of H42-HV integrated into home visiting compared with usual home visiting services in reducing postpartum weight retention (difference between pre-pregnancy weight and weight at 6 months postpartum) among pregnant and postpartum participants. The overall goal is to improve long-term cardiometabolic health.

Read the detailed description

There are four components of the H42-HV intervention: 1) Health coaching calls; 2) H42 web-based app for learning activities and goal setting functions; 3) Tracking of health behaviors (diet, exercise), and 4) Self-weighing (weekly). The overarching behavioral goals of the intervention are for participants to have lower postpartum weight retention at 6 months after delivery. Weight and behavioral goals will be promoted through the COACH Plan, a behavioral model guiding coaching calls, behavioral tracking targets and learning activities. Coaches will refer to home visitors for additional support and community resources, based on an established protocol.

  • Telephone health coaching calls by trained health coaches. Calls start at enrollment, between 20-33-weeks gestation through 6 months postpartum. Although coaching calls will occur by phone or Zoom (\~20 mins), when possible, some coach contact could occur at the time of home visits in person.
  • Online interactive learning activities. Literacy adaptation ensured Learning Activities are at \<5th grade reading level. All activities are translated into Spanish and culturally adapted to create a parallel program. Online learning activities contain embedded images (people and settings) that reflect the diversity of the investigators' target population, examples of activities that are readily available in the community and maximize the use of white space, large text and simple graphics to enhance readability and accessibility of the educational content. The investigators enhanced the platform to enable an interactive goal-setting functionality for participants to set health goals paced with participants' Learning Activities and calls. The online program is maintained and monitored by the study's health coach managers.
  • Health behavior tracking (diet and exercise). Participants will receive specific skill-building on how to track diet and exercise behaviors via mainstream mobile app or paper/pencil, using procedures from the investigators' current trial. Coaches will be able to discuss tracking data with participants. Mainstream tracking apps are available in both Spanish and English.
  • Weekly self-weighing. Participants will be asked to weigh themselves weekly at home using the participants' study scale.
03

Conditions studied

  • Postpartum Weight Retention
  • Pregnancy Weight Gain
  • Overweight and Obesity
  • Behavior, Health

Keywords

  • Behavioral Intervention
  • Early Childhood Home Visiting
  • Overweight
  • Obesity
  • Postpartum
  • Pregnancy
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant, ≤33 weeks gestation
  • Singleton pregnancy
  • Pre pregnancy ≥25.0 Kg/m\^2 (calculated based on self-reported pre pregnancy height and weight)
  • Able to provide
  • English or Spanish speaking
  • Completion of screening and baseline data collection
  • Willing to participate in the intervention and data collection procedure (e.g., home weights)

Exclusion criteria

Exclusion Criteria:

  • Type 1 diabetes or taking insulin prior to delivery
  • Pregnant with multiple fetuses
  • Unable to walk 1 block without pain or shortness of breath
  • Not cleared by the study's clinicians or home visiting program staff
  • Planning to relocate from area during next 1 year
  • Active substance abuse disorder (except marijuana)
  • Psychiatric or substance use related hospitalization in past 1 year
  • Active eating disorder
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Single group
Masking
Double (Investigator, Outcomes assessor)
Enrollment
360 participants (estimated)

Study arms

  • Experimental
    Healthy for Two-Health Coaching (H42)

    Those assigned to the intervention group will receive the 8 to 11 month H42 health coaching intervention in addition to usual home visiting and usual prenatal and postpartum care clinical services. Intervention duration will depend on the participant's gestational age at the of enrollment. Participants can be enrolled as early in pregnancy as 20 weeks gestation and as late as 33 weeks gestation. All participants would be enrolled for 6 months postpartum. Therefore, the minimum time in the intervention would be 8 months and maximum would be 11 months.

    Behavioral: Healthy for Two-Health Coaching (H42)

  • Active comparator
    Maintain Health in Pregnancy and Postpartum (mHIPP)

    Those assigned to the "usual home visiting plus" comparison group, called maintain health in pregnancy and postpartum (mHIPP), will receive the typical, evidence-based experience in participants' home visiting program in addition to the participants' usual prenatal and postpartum care clinical services. In addition, the investigators will provide a brief (less than 5 minutes) maternal warning signs educational video that is available in English or Spanish. The video was developed for a home visiting client audience and is publicly available, https://mdmom.org/warningsigns.

    Behavioral: Maintain Healthy in Pregnancy and Postpartum(mHIPP)

Interventions

  • BehavioralHealthy for Two-Health Coaching (H42)

    The H42-HV intervention includes health coaching calls, H42 web based app, mobile phone-based tracking.

  • BehavioralMaintain Healthy in Pregnancy and Postpartum(mHIPP)

    A brief video on maternal warning signs that is available in English or Spanish.

    Also known as: "Usual Home Visiting Plus"

06

What researchers measure

Primary outcomes

  1. Change in postpartum weight (retention)

    Difference between pre-pregnancy weight and weight at 6 months postpartum. Pre-pregnancy weight (baseline) will be self-reported and then confirmed by prenatal clinic medical records. 6 month postpartum weight will be obtained via BodyTrace study scales provided to all participants.

    Time frame: Baseline and 6 months postpartum

Secondary outcomes

  1. Change in gestational weight (gain)

    Difference between pre-pregnancy weight and delivery weight. Pre-pregnancy weight will be self-reported and then confirmed by prenatal clinic records. Delivery weight will be obtained via BodyTrace study scales provided to each participant.

    Time frame: Baseline and immediately before delivery

  2. Change in maternal diet as assessed by the Dietary Screener Questionnaire (DSQ)

    Dietary intake will be assessed using the NHANES 2009-10 Dietary Screener Questionnaire (DSQ) Eating Habits Questionnaire (28-items). Scoring equations exist to estimate daily intake of fruits/vegetables, dairy, added sugars, whole grains, and calcium.

    Time frame: Baseline, 37 weeks gestation, 2 months postpartum, 4 months postpartum, 6 months postpartum

  3. Change in maternal physical activity as assessed by the International Physical Activity Questionnaire (IPAQ)

    The Short Form International Physical Activity Questionnaire contains 9 items to collect data on health-related physical activity in the past seven days. Physical activity is categorized as high (at least one hour of moderate intensity exercise daily), moderate (approximately 30 minutes of moderate intensity exercise most days), or low (not meeting the criteria of high or moderate exercise).

    Time frame: Baseline, 37 weeks gestation, 2 months postpartum, 4 months postpartum, 6 months postpartum

  4. Maternal smoking habits as assessed by the Center for Disease Control and Prevention Pregnancy Risk Assessment Monitoring System (CDC PRAMS)

    A four-item portion of the PRAMS survey will be utilized to determine cigarette use before and during pregnancy.

    Time frame: Baseline

  5. Change in breastfeeding Practice as assessed by the Center for Disease Control and Prevention Infant Feeding Practices Survey (CDC IFPS)

    A 4-item portion of the CDC IFPS will be used at 2,4, and 6 months postpartum to assess current breastfeeding practice.

    Time frame: 2 months postpartum, 4 months postpartum, 6 months postpartum

  6. Breastfeeding Intention as assessed by the Center for Disease Control and Prevention Infant Feeding Practices Survey (CDC IFPS)

    A two-item portion of the CDC IFPS will be used to assess breastfeeding intention.

    Time frame: 37 weeks gestation

  7. Change in maternal depression as assessed by the Edinburgh Postpartum Depression scale

    The Edinburgh Postpartum Depression scale is a 10-item measure assessing changes in mood over the past seven days. The last question related to suicidal ideation has been removed. Mothers who score above 13 are likely to be suffering from a depressive illness of varying severity.

    Time frame: Baseline, 37 weeks gestation, 2 months postpartum, 4 months postpartum, 6 months postpartum

  8. Change in maternal sleep habits as assessed by the Pittsburgh Sleep Quality Index (PSQI)

    The PSQI is a 19-item questionnaire assessing sleep habits in the past seven days. Nineteen individual items generate seven "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The sum of scores for these seven components yields one global score (0-21) and higher scores indicate worse sleep quality.

    Time frame: Baseline, 2 months postpartum, 4 months postpartum, 6 months postpartum

  9. Change in maternal social support as assessed by the Functional Social Support Questionnaire (FSSQ)

    The FSSQ is an 8-item measure that evaluates confidant support and affective support. Responses are scored 1-5 and an average is calculated based on the response from all eight items. A higher score indicates greater perceived social support.

    Time frame: Baseline, 36-38 weeks prenatal, 2 months postpartum, 4 months postpartum, 6 months postpartum

  10. Maternal healthcare utilization as assessed by Medicaid data extraction

    Postpartum OBGYN visit and primary care provider visit by six months.

    Time frame: Up to 6 months after delivery

  11. Infant healthcare utilization as assessed by Medicaid data extraction

    Well-child visit appointments through six months of life.

    Time frame: Up to 6 months after delivery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Martin LM, McKinney CD, Escobar Acosta L, Coughlin JW, Jeffers NK, Solano-Umana A, Carson KA, Wang NY, Bennett WL, Bower KM. Remote Lifestyle Intervention to Reduce Postpartum Weight Retention: Protocol for a Community-Engaged Hybrid Type I Effectiveness-Implementation Randomized Controlled Trial. JMIR Res Protoc. 2025 Jan 7;14:e62847. doi: 10.2196/62847. PubMed 39773922 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2023 (actual). Primary completion is estimated for Dec 2026, 43 months after the start.

Of 84 non-industry interventional studies with no phase under Gestational Weight Gain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 38. This study's planned 43 months is above that.

Counting every sponsor, half of 84 studies reached it within 24 months; a quarter within 13 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2022
First posted
Nov 17, 2022
StartActual
Apr 25, 2023
Primary completionEst.
Dec 15, 2026
CompletionEst.
Dec 15, 2026
Last update
Jun 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05619705
Responsible party
Sponsor
First posted
Nov 17, 2022
Start date
Apr 25, 2023
Primary completion
Dec 15, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
Jun 8, 2026

Study contacts

Kelly M Bower, PhD, MSN/MPH
Contact
kbower1@jhu.edu
410-955-4280
Wendy Bennett, MD,MPH
Contact
wendy.bennett@jhmi.edu
410-502-6081
Kelly Bower, PhD, MSN/MPH
principal investigator · Johns Hopkins School of Nursing
Wendy Bennett, MD,MPH
principal investigator · Johns Hopkins School of Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion